ABCC1 and lung carcinoma: Previous reports have shown that ABCC1 is a negative biomarker associated with a decreased survival rate and an increased risk of relapse in colorectal cancer (Zhao et al., 2020), lung cancer (Fan et al., 2020), and breast cancer (Low et al., 2020).